Efficacy of Dapagliflozin on Type 2 Diabetic Patients with Chronic Heart Failure and Its Effect on Thickness of Epicardial Adipose Tissue-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Dapagliflozin on Type 2 Diabetic Patients with Chronic Heart Failure and Its Effect on Thickness of Epicardial Adipose Tissue

Published:2022 Issue:01 Volume:10 Page:1-7
ISSN:2326-3490
Container-title:Asian Case Reports in Vascular Medicine
language:
Short-container-title:ACRVM

Author:

叶炳华

Publisher

Hans Publishers

Reference24 articles.

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

2. The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure

3. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

4. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

5. 中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018 [J]. 中华心血管病杂志, 2018, 46(10): 760-789.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP